← All decks

General Surgery

Cancer of the Esophagus

Built from Maingot's Abdominal Operations

What’s inside

13 sections · 185 slides

  1. 01

    Overview

    • Topics covered

    1 slide

  2. 02

    Background and Causes

    Where the disease occurs, who it strikes, and the exposures behind it

    • Cancer of the esophagus in outline
    • Early descriptions and the first resections
    • From resection to reconstruction
    • Global burden of esophageal cancer
    • The Asian esophageal cancer belt
    • High-incidence areas within China
    • The shift from squamous cell cancer to adenocarcinoma
    • Etiologic factors and the two cell types
    • Smoking and alcohol
    • Genetic predisposition in squamous cell cancer
    • Aldehyde dehydrogenase 2 and the flushing response
    • Acetaldehyde handling after a drink
    • Which genotype carries the risk
    • Diet and environment in squamous cell cancer
    • Micronutrient deficiency and changing diet
    • Field cancerization and second cancers
    • Diseases that predispose to esophageal cancer
    • Why adenocarcinoma is rising in the West

    18 slides

  3. 03

    Screening, Surveillance and Prevention

    Finding cancer before it causes symptoms, and trying to stop it forming

    • Abrasive cytology in high-incidence areas
    • Lugol's iodine chromoendoscopy of an early squamous cancer
    • Narrow band imaging of the same lesion
    • Chromoendoscopy with Lugol's iodine
    • The Linxian nutritional intervention trial
    • Arguments against screening the population for Barrett's esophagus
    • Surveillance once Barrett's esophagus is found
    • Dysplasia grade and surveillance interval
    • The metaplasia-dysplasia-cancer sequence
    • Chemoprevention in Barrett's esophagus

    10 slides

  4. 04

    Clinical Presentation

    What patients complain of, and how the two cell types differ at the bedside

    • Symptoms of advanced esophageal cancer
    • Odynophagia, hoarseness and the clues they give
    • Two different patients behind the two cell types
    • Squamous cell cancer and adenocarcinoma compared

    4 slides

  5. 05

    Tumour Staging

    How deep, how many nodes, how far - and how the categories are grouped

    • Purpose of accurate staging
    • T categories for the primary tumour
    • Depth of invasion behind the T categories
    • Reading the T categories
    • N and M categories
    • Counting nodes for the N category
    • What changed in the revised TNM system
    • Histologic grade categories
    • Grade of differentiation
    • Stage groupings for squamous cell carcinoma
    • Stage groupings for adenocarcinoma
    • Why the two cell types are grouped differently
    • Levels of the esophagus used in staging
    • Levels of the esophagus
    • Lymph node stations of the esophagus
    • American Joint Committee on Cancer node stations
    • Staging tumours at the gastroesophageal junction
    • Siewert classification of junctional adenocarcinoma
    • Type I adenocarcinoma arising from Barrett's esophagus
    • Type II cardia cancer specimen and barium study
    • Siewert types I, II and III
    • Divisions of T1 tumours by the Japan Esophageal Society
    • Subdividing T1a and T1b

    23 slides

  6. 06

    Methods of Staging

    The investigations that answer depth, nodes and distant spread

    • What each staging test answers best
    • Barium contrast studies
    • Barium study of a stenotic tumour
    • Bronchoscopy
    • Computed tomography for distant disease
    • Computed tomography for local and nodal disease
    • Combined PET and CT of a hilar node
    • Endoscopic ultrasound and the wall layers
    • Endoscopic ultrasound of an early mucosal tumour
    • Accuracy and reach of endoscopic ultrasound
    • The non-traversable stricture
    • Percutaneous ultrasound of neck nodes
    • FDG-PET for the primary tumour
    • FDG-PET for regional nodes
    • Does PET change the operative decision
    • Thoracoscopic and laparoscopic staging

    16 slides

  7. 07

    Treatment of Early Cancer

    Removing the disease through the endoscope, and when that is not enough

    • Depth and nodal risk in early squamous cell cancer
    • 0%
    • Selecting lesions for endoscopic resection
    • Indications for endoscopic resection of esophageal cancer
    • Cap-assisted endoscopic mucosal resection
    • Results of endoscopic mucosal resection
    • Endoscopic submucosal dissection
    • Complications of endoscopic resection
    • The case against watching high-grade dysplasia
    • Invasive cancer hidden inside high-grade dysplasia
    • Localized resection in Barrett's cancer
    • Circumferential resection and whole-segment ablation
    • Photodynamic therapy
    • Radiofrequency ablation devices
    • Radiofrequency ablation in non-dysplastic Barrett's esophagus
    • Randomized trial of ablation for dysplastic Barrett's esophagus
    • Vagal-sparing and limited resection
    • Choosing between the three options

    18 slides

  8. 08

    Surgical Resection for Advanced Cancer

    Choosing the patient, the approach, the margins and the node clearance

    • Patient selection for esophagectomy
    • Predictors of morbidity and mortality
    • Risk scoring before esophagectomy
    • Pharyngolaryngoesophagectomy for cervical cancer
    • Reconstruction after cervical resection
    • Sacrificing the larynx, and the alternative
    • Three-phase (McKeown) esophagectomy
    • Phases of the Lewis-Tanner operation
    • The Lewis-Tanner operation
    • The left thoracotomy approach
    • The transhiatal approach
    • Abdominal esophagus and cardia tumours
    • Transthoracic and transhiatal resection compared
    • The argument over access
    • The randomized trial of transhiatal versus transthoracic resection
    • Choosing an approach by tumour site
    • Minimally invasive esophagectomy
    • Evidence for minimally invasive esophagectomy
    • Why the benefit is hard to prove
    • R0 resection and the axial margin
    • How long a proximal margin
    • Limits of margin status
    • Lateral margin and en bloc resection
    • Extent of lymphadenectomy
    • Standard, extended and three-field clearance
    • Standard and extended mediastinal lymphadenectomy
    • Total mediastinal lymphadenectomy
    • Nodal spread in squamous cell cancer
    • Infracarinal mediastinal dissection
    • Superior mediastinal dissection
    • Right recurrent laryngeal nerve node dissection
    • Abdominal lymphadenectomy at the celiac trifurcation
    • Cervical lymphadenectomy
    • Morbidity of three-field lymphadenectomy
    • Refining the indications
    • Criticism of three-field dissection
    • Nodal spread in Barrett's adenocarcinoma
    • En bloc resection results
    • Surgery for cardia cancer
    • The JCOG 9502 trial
    • Number of nodes removed and survival
    • ~10

    42 slides

  9. 09

    Reconstruction After Esophagectomy

    Which organ replaces the esophagus, by which route, and how it functions

    • The gastric conduit
    • Gastric conduit prepared for transposition to the neck
    • Drawbacks of the gastric conduit
    • Gastric emptying after esophagectomy
    • Colonic interposition
    • Jejunal reconstruction
    • Route of the conduit
    • Recurrent tumour and the reconstruction route

    8 slides

  10. 10

    Perioperative Care and Complications

    The complications that determine whether the operation succeeds

    • Cardiac events and atrial arrhythmia
    • Pulmonary complications
    • Reducing pulmonary complications
    • Anastomotic leak
    • Stapled versus hand-sewn anastomosis
    • Technical complications drive outcome
    • Improvement in leak outcomes over time

    7 slides

  11. 11

    Multimodal Treatment

    Radiotherapy, chemotherapy and chemoradiation around the operation

    • Neoadjuvant radiotherapy
    • Adjuvant radiotherapy
    • Randomized trials of neoadjuvant chemotherapy versus surgery
    • The Intergroup INT 0113 trial
    • The MRC OE02 trial
    • JCOG 9907 and the MAGIC trial
    • Meta-analyses of preoperative chemotherapy
    • Adjuvant chemotherapy
    • Randomized trials of neoadjuvant chemoradiation, first group
    • Randomized trials of neoadjuvant chemoradiation, remaining trials
    • Neoadjuvant chemoradiation trials
    • Meta-analysis of neoadjuvant chemoradiation
    • Definitive chemoradiation without surgery
    • The FFCD 9102 trial
    • The German chemoradiation trial
    • Why it is premature to abandon surgery
    • Local control and residual disease
    • Predicting response to treatment
    • PET/CT before and after chemoradiation therapy
    • The MUNICON trial
    • Results of the MUNICON trial
    • The MUNICON-2 trial
    • Newer drugs and radiation techniques

    23 slides

  12. 12

    Endoscopic Palliation

    Restoring swallowing when cure is no longer possible

    • Self-expanding metallic stents
    • Self-expanding metallic stent in situ
    • Metallic versus plastic prostheses
    • Problems with metallic stents
    • Restoring patency and choosing a stent
    • Stents near the upper esophageal sphincter

    6 slides

  13. 13

    Summary and Future Directions

    Where treatment stands, and what still has to be solved

    • Where treatment stands
    • Remaining problems
    • Points to carry away
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Maingot's Abdominal Operations, 12th Edition

    9 slides